AMERICAN VANGUARD CORP
For the period ended Sep 30, 2026. Filed Nov 9, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 9, 2026
AVD$0.82+0.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Stockholders’ Equity
For the Three and Nine Months Ended September 30, 2026
| Common Stock · Additional · Accumulated Other · Treasury Stock | ||||||||
|---|---|---|---|---|---|---|---|---|
| Shares | Amount | Paid-in Capital | ComprehensiveLoss | RetainedEarnings | Shares | Amount | Total | |
| Balance, January 1, 2026 | 34,923,562 | $3,492 | $117,106 | $(12,000) | $155,000 | 5,915,182 | $(71,201) | $192,397 |
| Stocks issued under ESPP | 68,714 | 7 | 256 | — | — | — | — | 263 |
| Foreign currency translation adjustment, net | — | — | — | 938 | — | — | — | 938 |
| Stock-based compensation | — | — | 186 | — | — | — | — | 186 |
| Stock options exercised; grants, termination and vesting of restricted stock units (net of shares in lieu of taxes) | (12,501) | (1) | (18) | — | — | — | — | (19) |
| Net loss | — | — | — | — | (4,145) | — | — | (4,145) |
| Balance, March 31, 2026 | 34,979,775 | $3,498 | $117,530 | $(11,062) | $150,855 | 5,915,182 | $(71,201) | $189,620 |
| Foreign currency translation adjustment, net | — | — | — | 1,323 | — | — | — | 1,323 |
| Stock-based compensation | — | — | 388 | — | — | — | — | 388 |
| Stock options exercised; grants, termination and vesting of restricted stock units (net of shares in lieu of taxes) | (128,836) | (13) | (63) | — | — | — | — | (76) |
| Net loss | — | — | — | — | (9,868) | — | — | (9,868) |
| Balance, June 30, 2026 | 34,850,939 | $3,485 | $117,855 | $(9,739) | $140,987 | 5,915,182 | $(71,201) | $181,387 |
| Foreign currency translation adjustment, net | — | — | — | (1,130) | — | — | — | (1,130) |
| Stocks issued under ESPP | 75,713 | 8 | 203 | — | — | — | — | 211 |
| Stock-based compensation | — | — | 327 | — | — | — | — | 327 |
| Stock options exercised; grants, termination and vesting of restricted stock units (net of shares in lieu of taxes) | 30,644 | 3 | (7) | — | — | — | — | (4) |
| Net loss | — | — | — | — | (17,668) | — | — | (17,668) |
| Balance, September 30, 2026 | 34,957,296 | $3,496 | $118,378 | $(10,869) | $123,319 | 5,915,182 | $(71,201) | $163,123 |
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
For the Three and Nine Months Ended September 30, 2025
| Common Stock · Additional · Accumulated Other · Treasury Stock | ||||||||
|---|---|---|---|---|---|---|---|---|
| Shares | Amount | Paid-in Capital | ComprehensiveLoss | RetainedEarnings | Shares | Amount | Total | |
| Balance, January 1, 2025 | 34,794,548 | $3,479 | $114,679 | $(18,729) | $204,882 | 5,915,182 | $(71,201) | $233,110 |
| Stocks issued under ESPP | 72,267 | 7 | 326 | — | — | — | — | 333 |
| Foreign currency translation adjustment, net | — | — | — | 1,825 | — | — | — | 1,825 |
| Stock-based compensation | — | — | 559 | — | — | — | — | 559 |
| Stock options exercised; grants, termination and vesting of restricted stock units (net of shares in lieu of taxes) | (16,785) | (1) | (10) | — | — | — | — | (11) |
| Net loss | — | — | — | — | (8,462) | — | — | (8,462) |
| Balance, March 31, 2025 | 34,850,030 | $3,485 | $115,554 | $(16,904) | $196,420 | 5,915,182 | $(71,201) | $227,354 |
| Foreign currency translation adjustment, net | — | — | — | 4,025 | — | — | — | 4,025 |
| Stock-based compensation | — | — | 422 | — | — | — | — | 422 |
| Stock options exercised; grants, termination and vesting of restricted stock units (net of shares in lieu of taxes) | (71,607) | (7) | (123) | — | — | — | — | (130) |
| Net loss | — | — | — | — | (849) | — | — | (849) |
| Balance, June 30, 2025 | 34,778,423 | $3,478 | $115,853 | $(12,879) | $195,571 | 5,915,182 | $(71,201) | $230,822 |
| Stocks issued under ESPP | 75,930 | 8 | 288 | — | — | — | — | 296 |
| Foreign currency translation adjustment, net | — | — | — | 1,473 | — | — | — | 1,473 |
| Stock-based compensation | — | — | 760 | — | — | — | — | 760 |
| Stock options exercised; grants, termination and vesting of restricted stock units (net of shares in lieu of taxes) | 116,334 | 11 | (16) | — | — | — | — | (5) |
| Net loss | — | — | — | — | (12,358) | — | — | (12,358) |
| Balance, September 30, 2025 | 34,970,687 | $3,497 | $116,885 | $(11,406) | $183,213 | 5,915,182 | $(71,201) | $220,988 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.